Most PlexusDx patients choose to refrigerate their in-use pens to maximize medication effectiveness and reduce potential injection discomfort
doi: 10.1186/s13722-025-00618-2 153 VolkowN
Oral GLP-1s for obesity saw a recent setback when in April (April 2025), Pfizer announced that it was discontinuing development of danuglipron, an oral GLP-1 receptor agonist, which was being investigated for chronic weight management, due to potential liver toxicity
An injectable TME-responsive nanocomposite hydrogel incorporating IL11R-targeted liposomes has also been developed for local delivery of cisplatin-loaded MnO2 along with a MYC inhibitor, enabling sustained drug release and reshaping of the immune microenvironment in MYC-amplified osteosarcoma (45)
The Data on Regain Studies following Tirzepatide discontinuation show that participants regain approximately two-thirds of their lost weight within one year of stopping
You found this not helpful 0 of 0 found this helpful Blue Raspberry Show More + Show Less - BOBBY E I love the feel of the L-Carnitine